E

Envoy Medical, Inc. COCH

$0.72 -$0.01-0.82% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Envoy Medical, Inc. is a U.S.-based medical technology company focused on hearing health and implantable hearing solutions. The company develops devices intended to treat hearing loss through fully implantable and partially implantable hearing systems, operating within the broader medical devices, audiology, and hearing restoration industries. Envoy Medical’s primary commercial and development focus has centered on implantable hearing technologies designed to improve hearing performance while reducing or eliminating the need for externally worn sound processors. The company’s revenue historically has been derived primarily from product-related activities, development efforts, and limited commercialization initiatives tied to hearing implant technologies.

The company is best known for its fully implantable cochlear implant platform and its earlier implantable hearing system technologies. Envoy Medical positions itself as a differentiated participant in the hearing implant market by emphasizing fully implanted solutions intended to offer cosmetic, lifestyle, and usability advantages compared with conventional externally worn hearing devices. The company traces its origins to hearing implant research and commercialization efforts developed over multiple decades and later transitioned into a publicly traded company through a business combination transaction completed in 2023.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Monday, August 10, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 9 and 13 (est)

Price History

Loading...
52-Week Range23% of range
Low
$0.36
Current
$0.72
High
$1.89
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

Corporate Info

Phone Number
877 900 3277
Address
4875 White Bear Parkway
White Bear Lake, MN 55110
Country
Year Founded

Headlines

8/21/2026 - Zacks Investment Research
8/10/2026 - Seeking Alpha - Healthcare